Trial Profile
A randomized, double-blind, placebo-controlled, multicenter parallel group phase III study Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin 40 mg (METEOR).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Atherosclerosis
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms METEOR
- 13 Oct 2009 Actual end date (May 2006) added as reported by ClinicalTrials.gov.
- 28 Mar 2007 Results have been published.
- 29 Aug 2006 Status change